Nerve action potential amplitude, a robust marker of diabetic peripheral neuropathy
Marie Monlun(Hôpital Cardiologique du Haut-Lévêque), Vincent Rigalleau(Université de Bordeaux), Kamel Mohammedi(Hôpital Cardiologique du Haut-Lévêque), Kalina Rajaobelina(Université de Bordeaux), Rechdi Ahdab, L. Alexandre(Hôpital Cardiologique du Haut-Lévêque), S. Poirot-Mazères(Centre Hospitalier Universitaire de Bordeaux), Laurence Blanco(Hôpital Cardiologique du Haut-Lévêque), M. Hugo(Hôpital Cardiologique du Haut-Lévêque)
Cited by 1
Related Papers
Trial of Lixisenatide in Early Parkinson’s Disease
|New England Journal of Medicine|2024|302
Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
|PLoS Medicine|2018|234
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
|Diabetologia|2021|168
Diet and risk of diabetic retinopathy: a systematic review
|European Journal of Epidemiology|2017|134
The influence of sex on renal function decline in people with Type 2 diabetes
|Diabetic Medicine|2014|78